A Study to Evaluate Efficacy and Safety of JTZ-951 Compared to Darbepoetin Alfa in Korean Renal Anemia Patients Receiving Hemodialysis.
Clinical trial NCT04027517 · COMPLETED
Trial details
- NCT number
- NCT04027517
- Sponsor
- JW Pharmaceutical
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-15
- Primary completion
- 2021-02-23
- Enrollment
- 172
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.